Physiological importance of ATP released from nerve terminals and its degradation to adenosine in humans.
Author(s) -
A Pelleg,
Geoffrey Burnstock
Publication year - 1990
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.82.6.2269
Subject(s) - medicine , adenosine , neuropharmacology , pharmacology
T he paper by Taddei et all in this issue of Circulation deals with two important physiological aspects of endogenous purine compounds, both of which have been controversial for quite some time. The first is the release of ATP from nerve terminals and the second, the antiadrenergic action of adenosine. In their study in humans, Taddei et al found evidence suggesting a) reflex vasoconstriction mediated in part by ATP and b) the modulation of this reflex by adenosine, a product of enzymatic degradation of ATP. The latter could be a manifestation of the antiadrenergic action of endogenous adenosine under experimental conditions that closely resemble physiological ones.' Thus, these observations demonstrate for the first time in humans that the release of ATP, its degradation to adenosine, and the inhibition of neurotransmitter release by adenosine constitute an important physiological regulatory feedback loop. The idea that some nerves release more than one transmitter was originally proposed by Burnstock2 in what has been termed the cotransmitter hypothesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom